Drugs Made In America Acquisition DMII Income Statement (2024-2025)

NASDAQ DMII

$10.14 +0.02 (+0.20%)

At close: Aug 20, 2026 · 4:00 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2024	Sep2025	Dec2025
Shares Outstanding (Entity) (Quarter)	14.38M	12.57M	13.70M
Operating items
Selling, General & Administrative (Quarter)		0.16M	0.24M
Operating Expenses (Quarter)		0.16M	0.24M
Operating Income (Quarter)		-0.16M	-0.24M
EBIT (Quarter)		-0.16M	-0.24M
Non-operating items
Interest & Investment Income (Quarter)		0.11M	4.82M
Non Operating Income (Quarter)		0.11M	4.57M
Net income details
EBT (Quarter)		-0.05M	4.59M
Profit After Tax (Quarter)		-0.05M	4.33M
Income from Continuing Operations (Quarter)		-0.05M	4.59M
Consolidated Net Income (Quarter)		-0.05M	4.59M
Income towards Parent Company (Quarter)		-0.05M	4.59M
Net Income towards Common Stockholders (Quarter)		-0.01M	2.07M
Additional items
EPS (Basic) (Quarter)		0.00	0.16
EPS (Diluted) (Quarter)		0.00	0.14
Shares Outstanding (Quarter)	12.50M	12.57M	13.29M
Shares Outstanding (Diluted) (Quarter)	12.50M	14.44M	14.43M
EBITDA (Quarter)		-0.16M	-0.24M